Morgan Stanley’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.6K | Sell |
|
|||||
|
2025
Q1 | $95.3K | Buy |
|
|||||
|
2024
Q4 | $73.7K | Sell |
|
|||||
|
2024
Q3 | $100K | Sell |
|
|||||
|
2024
Q2 | $76.2K | Sell |
|
|||||
|
2024
Q1 | $116K | Sell |
|
|||||
|
2023
Q4 | $283K | Buy |
|
|||||
|
2023
Q3 | $121K | Sell |
|
|||||
|
2023
Q2 | $131K | Sell |
|
|||||
|
2023
Q1 | $184K | Sell |
|
|||||
|
2022
Q4 | $222K | Sell |
|
|||||
|
2022
Q3 | $257K | Sell |
|
|||||
|
2022
Q2 | $166K | Sell |
|
|||||
|
2022
Q1 | $184K | Buy |
|
|||||
|
2021
Q4 | $162K | Buy |
|
|||||
|
2021
Q3 | $206K | Sell |
|
|||||
|
2021
Q2 | $220K | Buy |
|
|||||
|
2021
Q1 | $41K | Sell |
|
|||||
|
2020
Q4 | $69K | Buy |
|
|||||
|
2020
Q3 | $35K | Sell |
|
|||||
|
2020
Q2 | $78K | Buy |
|
|||||
|
2020
Q1 | $23K | Sell |
|
|||||
|
2019
Q4 | $58K | Buy |
|
|||||
|
2019
Q3 | $53K | Sell |
|
|||||
|
2019
Q2 | $53K | Sell |
|
|||||
|
2019
Q1 | $80K | Buy |
|
|||||
|
2018
Q4 | $11K | Buy |
|
|||||
|
2018
Q3 | $7K | Sell |
|
|||||
|
2018
Q2 | $8K | Buy |
|
|||||
|
2018
Q1 | $7K | Buy |
|
|||||
|
2017
Q4 | $2K | Sell |
|
|||||
|
2017
Q3 | $8K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $19K | Sell |
|
|||||
|
2016
Q2 | $31K | Sell |
|
|||||
|
2016
Q1 | $30K | Buy |
|
|||||
|
2015
Q4 | $30K | Buy |
|
|||||
|
2015
Q3 | $48K | Buy |
|